TWi Biotechnology, Inc. (6610.TWO)
TWD 9.57
(-19.58%)
TWD 9.57
(-19.58%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -160.85 Million TWD | -144.55% |
| 2022 | -65.77 Million TWD | -1499.64% |
| 2021 | -4.11 Million TWD | 95.37% |
| 2020 | -88.81 Million TWD | 16.19% |
| 2019 | -100.47 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -50.76 Thousand TWD | -1.27% |
| 2024 Q1 | -50.76 Thousand TWD | 17.02% |
| 2023 Q3 | -61.17 Thousand TWD | -206.06% |
| 2023 FY | - TWD | -144.55% |
| 2023 Q2 | -19.98 Thousand TWD | 0.0% |
| 2023 Q1 | -19.98 Thousand TWD | -3.35% |
| 2023 Q4 | -61.17 Thousand TWD | 0.0% |
| 2022 FY | - TWD | -1499.64% |
| 2022 Q3 | -19.34 Thousand TWD | 0.0% |
| 2022 Q4 | -19.34 Thousand TWD | 0.0% |
| 2021 FY | - TWD | 95.37% |
| 2020 FY | - TWD | 16.19% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -247.844% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 140.868% |
| Level Biotechnology Inc. | 98.7 Million TWD | 262.969% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -259.545% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | -123.056% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -537.487% |
| GlycoNex Incorporation | -126.82 Million TWD | -26.832% |
| VBI | -6.97 Million TWD | -2207.186% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | -11.943% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 837.538% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -807.464% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | -55.245% |
| Visgeneer Inc. | 973 Thousand TWD | 16632.066% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 52.617% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 117.177% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 261.12% |
| Neith Corporation | -33.61 Million TWD | -378.599% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 83.77% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -9160.622% |
| Enimmune corporation | -228.96 Million TWD | 29.745% |
| TaiRx, Inc. | -208.64 Million TWD | 22.904% |
| CHO Pharma, Inc. | -277.73 Million TWD | 42.082% |
| EirGenix Inc. | -664.4 Million TWD | 75.789% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 317.657% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 332.644% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 84.986% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | -42.218% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 561.729% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | -158.028% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -511.624% |
| RBC Bioscience Corporation | 36.54 Million TWD | 540.137% |
| BiOptic Inc. | 65.03 Million TWD | 347.328% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 76.43% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -387.357% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -192.92% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 137.102% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | -100.89% |
| NaviFUS Corp. | -55.79 Million TWD | -188.3% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -869.135% |
| Sinew Pharma Inc. | -163.63 Million TWD | 1.695% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | -161.556% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 183.605% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 29.037% |
| AP Biosciences Inc | -325.51 Million TWD | 50.584% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 84.601% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -348.745% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 652.204% |
| Intech Biopharm Corporation | -219.58 Million TWD | 26.745% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 76.142% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -257.85% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 124.539% |
| TCI GENE Inc. | 25.98 Million TWD | 719.133% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | -45.39% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 43.317% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | -10.199% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 1261.422% |
| PharmaEngine, Inc. | 347.3 Million TWD | 146.316% |
| Savior Lifetec Corporation | 219.6 Million TWD | 173.248% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 193.397% |
| OBI Pharma, Inc. | -855.08 Million TWD | 81.188% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | -73.781% |
| Acepodia, Inc. | -764.51 Million TWD | 78.96% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 65.038% |